相关实验视频
Updated: Jun 10, 2026
07:35
Gene Transfer for Ischemic Heart Failure in a Preclinical Model
Published on: May 15, 2011
12.5K
对转化生长因子-β信号的后心脏病发作基因疗法调节了心脏病发作组织动态,减弱了左心室重塑和心力衰竭
Hideshi Okada1, Genzou Takemura, Ken-ichiro Kosai
1Second Department of Internal Medicine, Gifu University School of Medicine, Japan.
Circulation
|May 4, 2005
概括
在心肌梗塞 (MI) 后抑制转化生长因子-β (TGF-β) 信号传递,通过减少纤维化,改善了存活率和心脏功能. 这种基因疗法在MI后的亚急性阶段最有效.
科学领域:
- 心血管生物学 心血管生物学
- 再生医学是一种再生医学.
- 分子心脏病学分子心脏病学
背景情况:
- 心肌梗塞 (MI) 通常导致心脏纤维化和渐进性心力衰竭.
- 转化生长因子-β (TGF-β) 信号传递在心脏中风后心脏重塑中起着关键作用.
研究的目的:
- 为了研究抑制TGF-β信号传递在心脏纤维化和心室重塑后心脏病发作后的治疗潜力.
- 评估TGF-β抑制对心脏功能和心脏病发作后的存活率的影响.
主要方法:
- 在小鼠中,通过冠状动脉绑定诱导心肌梗塞 (MI).
- 含有可溶性TGF-βII型受体的腺病毒 (Ad.CAG-sTbetaRII) 用于抑制TGF-β信号传递.
- 分析了对生存,心室重塑,心脏纤维化和肌纤维细胞亡的影响.
主要成果:
- sTbetaRII治疗显著改善了心脏病后的生存率和减弱的心室扩张.
- 在接受治疗的小鼠中观察到心脏纤维化减少和心脏梗塞收缩增强.
- 抑制肌纤维细胞亡和心脏梗塞收缩有助于改善结果;如果延迟到慢性阶段,治疗是无效的.
结论:
- 针对TGF-β信号的基因治疗有效地减轻心脏重塑和MI后纤维化.
- 这些发现表明,TGF-β抑制是心脏病发作后心力衰竭的潜在治疗方法,特别是在亚急性阶段服用时.
更多相关视频
相关概念视频
01:16TGF - β Signaling Pathway
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...